JENNIFER WILLIAMS: Open Payments
NPI 1003007279 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,022 in 84 payments from 11 companies in 2025. Trend: 2023 $418 · 2024 $1,160 · 2025 $2,022
Food & beverage: $1,873Education: $149
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $816 |
| ABBVIE INC. | 27 | $445 |
| Regeneron Healthcare Solutions, Inc. | 7 | $242 |
| Lilly USA, LLC | 5 | $231 |
| Amgen Inc. | 3 | $66 |
| GENZYME CORPORATION | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $36 |
| UCB, Inc. | 1 | $17 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, EBGLYSS, TALTZ, OTEZLA, COSENTYX.
Industry payments across WA — which companies pay providers there.
